A looming Supreme Court ruling will answer questions about the legality of the Affordable Care Act mandate for providing some ...

Adam Colborn, JD, of AMCP, discusses the complexities of drug pricing and what policymakers must consider in efforts to ...

Fluctuating LDL and total cholesterol levels in older adults may indicate increased dementia and cognitive decline risk.

Research found that ibrutinib reduces red blood cell aggregation in patients with chronic lymphocytic leukemia (CLL), while ...

According to research, PSAT1, PSRC1, COLEC12, HP, and PLLP may play a role in small cell lung cancer metabolism, immune ...

Panelists discuss how step-up dosing protocols reduce cytokine release syndrome (CRS) risk in patients with high-risk disease ...

Panelists discuss the most common logistical challenges encountered when implementing bispecific therapies in both academic ...

Suzetrigine (Journavx) is the first new drug approved to treat acute pain in over 20 years and the first to be classified as ...

Travis Brewer, vice president of payer and public health strategy/relations at Texas Oncology, shared that value-based ...

Adam Colborn, JD, of AMCP, discussed how President Trump's rescission of several Biden-era executive orders may impact ...

Panelist discusses how patient advocacy groups act as critical bridges between patients, researchers, and health care providers, ultimately improving recognition, treatment, and quality of life for ...

The asymptomatic nature of glaucoma makes it imperative to get consistent screening to catch the condition early.